With an experienced team comprised of around 200 highly skilled professionals, the company is able to span the entire value chain of biosimilar drug development, from market analysis and target definition by protein analytics, to the development of production processes, to clinical trials and the regulatory approval process. * Application of AI‑based tools and advanced analytics for market analysis, forecasting, scenario simulation, and decision support * Lead development of robust business cases, including valuation, scenario modeling, sensitivity analyses, and risk assessments * Practical experience in using AI, advanced analytics, and digital tools for strategic analysis and decision support
mehr